https://vitalspanwire.com/news/menarini-bofanglutide-europe-licenseVitalspan Wireen2026-09-07T21:02:37.866ZMenarini licenses European rights to investigational GLP-1 drug bofanglutidehttps://vitalspanwire.com/news/met-heft-metformin-heart-failure-outcomes-analysisVitalspan Wireen2026-09-07T16:05:47.780ZMet-HeFT found no significant cardiovascular benefit from metformin in heart failurehttps://vitalspanwire.com/news/pelacarsen-horizon-cardiovascular-endpoint-lpaVitalspan Wireen2026-09-07T16:02:27.417ZPelacarsen misses cardiovascular endpoint despite lowering Lp(a), Novartis reportshttps://vitalspanwire.com/news/folic-acid-diabetes-risk-coronary-heart-disease-studyVitalspan Wireen2026-09-07T15:58:12.291ZFolic acid use linked to lower diabetes risk in coronary heart disease studyhttps://vitalspanwire.com/news/midlife-growth-hormone-receptor-disruption-mouse-lifespanVitalspan Wireen2026-09-07T15:56:13.521ZDisabling growth-hormone receptors in midlife extended mouse lifespanhttps://vitalspanwire.com/news/pancreatic-cancer-peptide-dna-vaccines-early-immune-responsesVitalspan Wireen2026-09-07T15:53:48.287ZPersonalized pancreatic-cancer vaccines elicit immune responses in early trialshttps://vitalspanwire.com/news/early-mitochondrial-stress-citrate-mouse-heart-protectionVitalspan Wireen2026-09-07T15:51:02.820ZEarly mitochondrial stress protected adult mouse hearts from chemotherapy injury